Patients (pts) with Optimized Hemophagocytic Lymphohistiocytosis (HLH) Inflammatory (OHI) Index-Confirmed Diagnosis of Malignancy-Associated HLH (mHLH) and Emapalumab Treatment

Poster is available to registered attendees only via the ASH annual meeting virtual platform, as per congress regulations. 

Session Name: 201. Granulocytes, Monocytes, and Macrophages: Poster III 

Session Date: Monday, December 9, 2024 

Presentation Time: 6:00 PM - 8:00 PM 

Location: San Diego Convention Center, Halls G-H

Link to Published Abstract